Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HealthLynked (HLYK) Interest Expenses (2016 - 2023)

Historic Interest Expenses for HealthLynked (HLYK) over the last 8 years, with Q2 2023 value amounting to $39124.0.

  • HealthLynked's Interest Expenses rose 77174.69% to $39124.0 in Q2 2023 from the same period last year, while for Mar 2024 it was $39124.0, marking a year-over-year decrease of 6582.7%. This contributed to the annual value of $21331.0 for FY2023, which is 8060.82% down from last year.
  • HealthLynked's Interest Expenses amounted to $39124.0 in Q2 2023, which was up 77174.69% from $110000.0 recorded in Q3 2022.
  • HealthLynked's 5-year Interest Expenses high stood at $110000.0 for Q3 2022, and its period low was -$1623.0 during Q2 2021.
  • Its 5-year average for Interest Expenses is $41976.4, with a median of $51473.5 in 2019.
  • Its Interest Expenses has fluctuated over the past 5 years, first plummeted by 10277.83% in 2021, then skyrocketed by 257119.96% in 2022.
  • Over the past 5 years, HealthLynked's Interest Expenses (Quarter) stood at $67856.0 in 2019, then decreased by 16.55% to $56625.0 in 2020, then tumbled by 89.3% to $6061.0 in 2021, then surged by 1714.88% to $110000.0 in 2022, then plummeted by 64.43% to $39124.0 in 2023.
  • Its Interest Expenses was $39124.0 in Q2 2023, compared to $110000.0 in Q3 2022 and $4488.0 in Q2 2022.